Revolution Medicines Stock Price

-0.25 (-1.32%)
Upgrade to Real-Time
Regular Market
Volume 91,511
Bid Price 18.60
Ask Price 18.64
News -
Day High 18.93


52 Week Range


Day Low 18.43
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Revolution Medicines Inc RVMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.25 -1.32% 18.62 11:04:44
Open Price Low Price High Price Close Price Prev Close
18.89 18.43 18.93 18.87
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,055 91,511 $ 18.68 $ 1,709,710 - 14.08 - 34.16
Last Trade Time Type Quantity Stock Price Currency
11:05:01 3 $ 18.60 USD


Draw Mode:

Revolution Medicines Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.38B 74.25M 62.52M $ 29.39M $ - -2.57 -6.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.69M 1.00%

more financials information »

Revolution Medicines News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RVMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week18.5719.4317.3418.651,374,5900.050.27%
1 Month16.5921.0715.63518.171,048,6172.0312.24%
3 Months25.7327.489914.0819.21771,476-7.11-27.63%
6 Months27.5027.5014.0820.57667,523-8.88-32.29%
1 Year33.7134.1614.0823.98581,410-15.09-44.76%
3 Years29.3556.1814.0830.21523,016-10.73-36.56%
5 Years29.3556.1814.0830.21523,016-10.73-36.56%

Revolution Medicines Description

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.